Pan-European network for the study and clinical management of drug resistant tuberculosis

This proposal will establish an integrated and synergistic network to address the challenge of multiple drug resistant tuberculosis (MDR-TB) facing the EU. The objective will be attained through the establishment of a European consortium of expert partners with extensive experience in the conduct of basic and clinical research relating to MDR-TB, TB control and epidemiology.

Short name and number: 
TB PAN-NET (223681)
Name of US Partner: 
University of Medicine and Dentistry of New Jersey
Contact: 

UNIVERSITA VITA-SALUTE SAN RAFFAELE

Participating Countries: 
Belgium
Croatia
Denmark
Estonia
Finland
France
Germany
Italy
Latvia
Lithuania
Norway
Poland
Rumania
Slovenia
Sweden
Switzerland
United Kingdom
United States
Area: 

Health

Category: 

FP7 Project with U.S. partner